Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics
暂无分享,去创建一个
P. Gibson | A. Boussioutas | G. Hold | M. Sparrow | E. Wright | M. Ward | A. Jois | R. Little